EGFR Mutant NSCLC Post Osimertinib
Podcast | English | 31 Min
Image For Activity Cover
No Credit Offered
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined by two thoracic medical oncologists, Dr. Xiuning Le and Dr. Hidehito Horinouchi, both global experts in targeted therapy.
Dr. Stephen Liu
Dr. Xiuning Le
Dr. Hidehito Horinouchi
Powered By